FDA's OxyContin Ruling May Spur New Battles Over Generics

By Rachel Slajda
April 23, 2013, 2:54 PM EDT

Last week's decision by the U.S. Food and Drug Administration to block generic versions of the oft-abused painkiller OxyContin could embolden makers of other top-selling branded drugs to push the agency...

Already a subscriber? Click here to view full article